A detailed history of Barclays PLC transactions in National Research Corp stock. As of the latest transaction made, Barclays PLC holds 51,331 shares of NRC stock, worth $861,847. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,331
Previous 51,331 -0.0%
Holding current value
$861,847
Previous $1.18 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$20.61 - $26.17 $419,021 - $532,062
20,331 Added 65.58%
51,331 $1.18 Million
Q2 2024

Aug 14, 2024

SELL
$22.95 - $39.34 $147,339 - $252,562
-6,420 Reduced 17.16%
31,000 $712,000
Q1 2024

May 15, 2024

BUY
$36.87 - $41.2 $135,386 - $151,286
3,672 Added 10.88%
37,420 $1.48 Million
Q4 2023

Feb 15, 2024

BUY
$39.05 - $46.39 $908,459 - $1.08 Million
23,264 Added 221.9%
33,748 $1.34 Million
Q3 2023

Nov 07, 2023

SELL
$41.8 - $46.78 $7,314 - $8,186
-175 Reduced 1.64%
10,484 $465,000
Q2 2023

Aug 03, 2023

SELL
$40.78 - $46.7 $271,431 - $310,835
-6,656 Reduced 38.44%
10,659 $464,000
Q1 2023

May 04, 2023

BUY
$38.17 - $47.17 $295,397 - $365,048
7,739 Added 80.82%
17,315 $753,000
Q4 2022

Feb 13, 2023

BUY
$35.23 - $41.21 $94,980 - $111,102
2,696 Added 39.19%
9,576 $357,000
Q3 2022

Nov 03, 2022

SELL
$33.58 - $40.66 $4,096 - $4,960
-122 Reduced 1.74%
6,880 $274,000
Q2 2022

Aug 12, 2022

BUY
$31.87 - $40.9 $82,160 - $105,440
2,578 Added 58.27%
7,002 $268,000
Q1 2022

May 16, 2022

SELL
$36.33 - $42.25 $455,905 - $530,195
-12,549 Reduced 73.94%
4,424 $176,000
Q4 2021

Feb 14, 2022

BUY
$40.05 - $49.0 $298,252 - $364,903
7,447 Added 78.18%
16,973 $704,000
Q3 2021

Nov 09, 2021

BUY
$42.17 - $54.5 $218,482 - $282,364
5,181 Added 119.24%
9,526 $402,000
Q2 2021

Aug 13, 2021

SELL
$43.54 - $51.55 $406,141 - $480,858
-9,328 Reduced 68.22%
4,345 $199,000
Q1 2021

May 13, 2021

BUY
$42.92 - $54.13 $183,525 - $231,459
4,276 Added 45.5%
13,673 $640,000
Q4 2020

Feb 11, 2021

SELL
$42.75 - $58.98 $81,139 - $111,944
-1,898 Reduced 16.8%
9,397 $402,000
Q3 2020

Nov 12, 2020

SELL
$46.51 - $59.98 $9,302 - $11,996
-200 Reduced 1.74%
11,295 $556,000
Q2 2020

Aug 12, 2020

BUY
$42.29 - $59.2 $251,118 - $351,529
5,938 Added 106.86%
11,495 $669,000
Q1 2020

May 13, 2020

SELL
$35.01 - $70.35 $227,074 - $456,290
-6,486 Reduced 53.86%
5,557 $254,000
Q4 2019

Feb 10, 2020

BUY
$55.77 - $67.47 $303,890 - $367,644
5,449 Added 82.64%
12,043 $794,000
Q3 2019

Nov 14, 2019

SELL
$55.58 - $67.42 $64,472 - $78,207
-1,160 Reduced 14.96%
6,594 $381,000
Q2 2019

Aug 14, 2019

BUY
$38.52 - $57.59 $146,761 - $219,417
3,810 Added 96.6%
7,754 $447,000
Q1 2019

May 15, 2019

BUY
$37.2 - $40.0 $141,694 - $152,360
3,809 Added 2821.48%
3,944 $152,000
Q4 2018

Feb 14, 2019

SELL
$36.2 - $40.0 $153,488 - $169,600
-4,240 Reduced 96.91%
135 $5,000
Q3 2018

Nov 14, 2018

BUY
$35.8 - $40.0 $121,540 - $135,800
3,395 Added 346.43%
4,375 $169,000
Q2 2018

Aug 14, 2018

SELL
$28.45 - $38.35 $67,483 - $90,966
-2,372 Reduced 70.76%
980 $37,000
Q1 2018

May 15, 2018

BUY
$28.3 - $38.45 $47,345 - $64,326
1,673 Added 99.64%
3,352 $98,000
Q4 2017

Feb 14, 2018

BUY
$31.4 - $38.55 $45,812 - $56,244
1,459 Added 663.18%
1,679 $63,000
Q3 2017

Nov 14, 2017

BUY
$29.4 - $37.9 $6,468 - $8,338
220
220 $8,000

Others Institutions Holding NRC

About NATIONAL RESEARCH CORP


  • Ticker NRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 24,767,100
  • Market Cap $416M
  • Description
  • National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-re...
More about NRC
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.